Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Active Biotech ACTI Apr 20, 2018 3.01 +7.50   
 AddLife AB ALIFB Apr 20, 2018 181.50 +2.54   
 Arjo B ARJOB Apr 20, 2018 24.85 -0.60   
 AstraZeneca AZN Apr 20, 2018 597.80 -0.10   
 Attendo AB ATT Apr 20, 2018 84.45 +1.62   
 Bactiguard Holding AB BACTIB Apr 20, 2018 24.30 +1.25   
 Biogaia B BIOGB Apr 20, 2018 451.00 -0.77   
 Bioinvent BINV Apr 20, 2018 1.88 -0.95   
 Biotage BIOT Apr 20, 2018 88.40 +1.61   
 Boule Diagnostics BOUL Apr 20, 2018 283.50 +3.09   
 Camurus AB CAMX Apr 20, 2018 113.80 -0.18   
 Capio AB CAPIO Apr 20, 2018 39.00 -0.13   
 Elekta B EKTAB Apr 20, 2018 91.50 -0.28   
 Feelgood FEEL Apr 20, 2018 3.68 +1.10   
 Follicum AB FOLLI Apr 20, 2018 3.43 +2.39   
 Getinge B GETIB Apr 20, 2018 95.58 +0.48   
 GHP Specialty Care AB GHP Apr 20, 2018 9.14 -1.19   
 Humana AB HUM Apr 20, 2018 50.80 +0.40   
 Karo Pharma AB KARO Apr 20, 2018 33.50 +0.90   
 MedCap AB MCAP Apr 20, 2018 68.20 0.00   
 Medivir B MVIRB Apr 20, 2018 41.30 +0.73   
 Moberg Pharma AB MOB Apr 20, 2018 26.50 -1.85   
 NeuroVive Pharmaceutic.. NVP Apr 20, 2018 2.27 -2.58   
 Oasmia Pharmaceutical OASM Apr 20, 2018 5.19 +4.64   
 Orexo ORX Apr 20, 2018 37.60 +0.40   
 Ortivus A ORTIA Apr 20, 2018 5.35 +6.57   
 Ortivus B ORTIB Apr 20, 2018 2.31 0.00   
 PExA AB PEXAB Apr 20, 2018 3.60 -2.70   
 Probi PROB Apr 20, 2018 476.40 -0.58   
 RaySearch Laboratories RAYB Apr 20, 2018 127.50 -1.09   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now